Area: Strategy
A Case Against Experience as a Central Driver of Innovation
Are older inventors weighed down by obsolete knowledge? Young inventors don’t carry that burden
A Broader Measure of Value Creation at Corporations
A tool in the debate over shareholder primacy and wealth disparities
$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents
The figure is a subset, not covering huge expense of extended patents on high-priced biologics like Humira